Embourg, Belgium

Michelle Deberg

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2008-2015

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Michelle Deberg: Innovator in Biomarker Research

Introduction

Michelle Deberg is a prominent inventor based in Embourg, Belgium, known for her significant contributions to the field of biomarker research. With a total of seven patents to her name, she has made remarkable strides in understanding and diagnosing osteoarthritis and other aging-related diseases. Her work has the potential to greatly impact the medical community and improve patient outcomes.

Latest Patents

Among her latest patents is a groundbreaking invention related to a biomarker for osteoarthritis and/or other aging-related diseases. This invention focuses on identifying a biomarker whose abundance in biological samples changes in subjects suffering from these conditions. The applications of this biomarker are extensive, including its use in diagnosing osteoarthritis, determining prognosis for affected individuals, and monitoring the efficacy of treatments for these diseases.

Career Highlights

Michelle has worked with esteemed institutions such as Université de Liège, where she has contributed to advancing research in her field. Her innovative approach and dedication to her work have established her as a leading figure in biomarker research.

Collaborations

Throughout her career, Michelle has collaborated with notable professionals, including Yves Henrotin and Jean-Yves Reginster. These partnerships have further enriched her research and expanded the impact of her inventions.

Conclusion

Michelle Deberg's contributions to biomarker research exemplify her commitment to improving healthcare through innovation. Her work not only enhances our understanding of osteoarthritis and aging-related diseases but also paves the way for more effective diagnostic and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…